Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Queensland Health
QuintilesIMS
Cantor Fitzgerald
Baxter
UBS
Cerilliant
Novartis
Harvard Business School
Colorcon

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202984

« Back to Dashboard
NDA 202984 describes CLONIDINE HYDROCHLORIDE , which is a drug marketed by Anchen Pharms and Par Pharm and is included in four NDAs. It is available from fifty-five suppliers. Additional details are available on the CLONIDINE HYDROCHLORIDE profile page.

The generic ingredient in CLONIDINE HYDROCHLORIDE is chlorthalidone; clonidine hydrochloride. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

Summary for NDA: 202984

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202984

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 202984

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL 202984 ANDA Par Pharmaceutical, Inc. 10370-257 10370-257-02 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-257-02)
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL 202984 ANDA Par Pharmaceutical, Inc. 10370-257 10370-257-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-257-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength0.1MG
Approval Date:Sep 30, 2013TE:AB1RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength0.2MG
Approval Date:Sep 30, 2013TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
US Department of Justice
McKinsey
Federal Trade Commission
Cantor Fitzgerald
Fish and Richardson
Teva
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot